Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04365465 · ClinicalTrials.gov registry record · NA

BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control

A NA study of Opioid Use Disorder and Pain, Postoperative, sponsored by Grace Lim, MD, MS.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04365465 is a NA study of Opioid Use Disorder and Pain, Postoperative that has completed, run by Grace Lim, MD, MS. The registered enrollment target is 60 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04365465, a NA study of Opioid Use Disorder and Pain, Postoperative, has completed, sponsored by Grace Lim, MD, MS.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This is a randomized, placebo controlled and natural-history controlled trial to investigate the effectiveness of NSS-2 BRIDGE® for postpartum women with AND without opioid use disorder (OUD). The purpose of this pilot investigation is to establish feasibility/acceptability of the trial design.

Interventions

  • OTHER Active control
  • DEVICE NSS-2 Bridge
  • DEVICE Inactive NSS-2 Bridge

Study Locations (1)

Pennsylvania

  • UPMC Magee Womens Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-08-17
Est. Completion 2021-06-30
Phase NA

Sponsor

Grace Lim, MD, MS

10 total trials

What the Registry Record Tells You About NCT04365465

The ClinicalTrials.gov registry entry for NCT04365465 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Grace Lim, MD, MS, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Active control is the first listed.

NCT04365465 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04365465 about?

NCT04365465 is a clinical study titled "BRIDGE Percutaneous Nerve Stimulation for Cesarean Delivery Pain Control". This is a randomized, placebo controlled and natural-history controlled trial to investigate the effectiveness of NSS-2 BRIDGE® for postpartum women with AND without opioid use disorder (OUD). The purpose of this pilot investigation is to establish feasibility/acceptability of the trial design.

What is the current status of trial NCT04365465?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-08-17. Estimated completion is 2021-06-30.

What conditions does trial NCT04365465 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Pain, Postoperative.

What interventions are being tested in trial NCT04365465?

The interventions under investigation include: Active control (OTHER), NSS-2 Bridge (DEVICE), Inactive NSS-2 Bridge (DEVICE).

Who is sponsoring clinical trial NCT04365465?

This trial is sponsored by Grace Lim, MD, MS, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04365465 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.